SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Fredun Pharmaceuticals

BSE: 539730 29 Sep 2025
Healthcare
₹ 1228.95
Fredun Pharmaceuticals Limited specializes in Pharmaceuticals within the Healthcare sector.

Fredun Pharmaceuticals - Share Price & Details

Market Cap
₹617.0
High /Low
1,355 / 635.0
Stock P/E
26.3
Book Value
₹299.0
Dividend Yield
0.05
ROCE
18.9
ROE
₹15.8
Face Value
10.0
PEG Ratio
0.54
EVEBITDA
₹12.6
Debt
166
CMP / FCF
-27.6
Debt to equity
₹1.18
NP Ann
20.8
High price all time
1,428
Piotroski score
₹4.0
Graham Number
578.0
No. Eq. Shares
0.47
Net CF
₹3.47
Net profit
23.4
Price to book value
4.36
Interest Coverage
₹2.27
Low price all time
12.5
Industry PE
33.0
Reserves
₹137
Free Cash Flow
₹-34.9

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Fredun Pharmaceuticals LimitedNANANANA617.026.3
KILITCH DRUGS (INDIA) LTD.376.1747.94341.222.9859621.3
VENUS REMEDIES LTD.1398.5116.91318.58.7558712.6

Peer Comparison Chart


About Fredun Pharmaceuticals

Fredun Pharmaceuticals Limited, with Security Code 539730, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Fredun Pharmaceuticals announces board meeting date

(23 Sep 2025)
Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 September 2025.
Read more →

Around 107 BSE-Listed Key Dividend Stocks to Watch from September 22 to 26: Check Weekly Full List of Stocks

(20 Sep 2025)
Monday will kick off with a packed slate of dividend declarations and corporate moves. Maharashtra Scooters leads with a massive Rs 160...
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Financial Performance and Growth

(09 Sep 2025)
Fredun Pharmaceuticals has achieved a new 52-week high, driven by impressive quarterly results, including a 52.06% increase in net sales and a 63.9% rise in...
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Market Confidence and Growth Metrics

(25 Aug 2025)
Fredun Pharmaceuticals has achieved a new 52-week high stock price of Rs. 1285, reflecting strong market confidence and impressive performance.
Read more →

Fredun Pharmaceuticals Achieves 52-Week High Amid Strong Financial Growth and Market Outperformance

(22 Aug 2025)
Fredun Pharmaceuticals has achieved a new 52-week high in stock price, reflecting strong performance in the Pharmaceuticals & Biotechnology sector.
Read more →

Small-cap pharma stock edges higher despite stock market sell-off; here's why

(16 Aug 2025)
Stock Market Today: Small-cap pharma stock — Fredun Pharmaceuticals — edged higher during the intraday trade on Thursday despite the stock...
Read more →